What is it about?
A significant advance in the HCC molecular field pushes researchers to search for the possibility of detecting diagnostic/prognostic serological and molecular markers and scores including AFP, Des-gamma carboxy prothrombin, genes (allelic imbalance [AI] in microsatellites [MSs]), proteins and miRNAs that may act as red flags to aid in the early detection of HCC recurrence. Our review has focused on the possible molecular onco-drivers’ for HCC recurrence post-LT that may represent diagnostic/prognostic tools and scoring models for the proper selection of LT candidates with HCC.
Featured Image
Photo by julien Tromeur on Unsplash
Why is it important?
Recurrence after liver transplantation (LT) for hepatocellular carcinoma (HCC) is one of the commonest causes of cancer-related mortality. Thus, advances in the HCC molecular features have paid researchers great attention to identifying the different risk factors that could aid in liver cancer initiation and progression for earlier prediction of post-operative HCC recurrence risk.
Perspectives
Read the Original
This page is a summary of: Molecular Clues for Prediction of Hepatocellular Carcinoma Recurrence After Liver Transplantation, Journal of Clinical and Experimental Hepatology, September 2023, Elsevier,
DOI: 10.1016/j.jceh.2023.02.006.
You can read the full text:
Contributors
The following have contributed to this page